首页 > 最新文献

Obesity Science & Practice最新文献

英文 中文
Hyperinsulinemia is a probable trigger for weight gain and hyperphagia in individuals with Prader-Willi syndrome. 高胰岛素血症可能是普拉德-威利综合征患者体重增加和食欲亢进的诱因。
IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-02-17 eCollection Date: 2023-08-01 DOI: 10.1002/osp4.663
Frederick A Kweh, Carlos R Sulsona, Jennifer L Miller, Daniel J Driscoll

Objective: Prader-Willi syndrome (PWS) is the most frequently diagnosed genetic cause of early childhood obesity. Individuals with PWS typically progress through 7 different nutritional phases during their lifetime. The main objective of this study was to assess potential factors, particularly insulin, that may be responsible for the weight gains in sub-phase 2a and their role in the subsequent increase in fat mass and obesity in sub-phase 2b and insatiable appetite in phase 3.

Methods: Fasting plasma insulin levels were measured in children with PWS between the ages of 0-12 years and in age-matched non-PWS participants with early-onset major (clinically severe) obesity (EMO) and in healthy-weight sibling controls (SC).

Results: Participants with PWS in nutritional phases 1a and 1b had plasma insulin levels comparable to SC. However, the transition from phase 1b up to phase 3 in the PWS group was accompanied by significant increases in insulin, coinciding in weight gains, obesity, and hyperphagia. Only individuals with PWS in phase 3 had comparable insulin levels to the EMO group who were higher than the SC group at any age.

Conclusions: Elevated insulin signaling is a probable trigger for weight gain and onset of hyperphagia in children with Prader-Willi syndrome. Regulating insulin levels early in childhood before the onset of the early weight gain may be key in modulating the onset and severity of obesity and hyperphagia in individuals with PWS, as well as in other young children with non-PWS early-onset obesity. Preventing or reversing elevated insulin levels in PWS with pharmacological agents and/or through diet restrictions such as a combined low carbohydrate, low glycemic-load diet may be a viable therapeutic strategy in combating obesity in children with PWS and others with early childhood obesity.

目的:普拉德-威利综合征(PWS)是导致儿童早期肥胖最常见的遗传病因。PWS患者一生中通常会经历7个不同的营养阶段。本研究的主要目的是评估可能导致第 2a 亚阶段体重增加的潜在因素,尤其是胰岛素,以及它们在随后的第 2b 亚阶段脂肪量增加和肥胖以及第 3 阶段贪得无厌的食欲中的作用:方法:对0-12岁患有PWS的儿童、与年龄相匹配的非PWS早期重度(临床严重)肥胖(EMO)患者以及健康体重的兄弟姐妹对照组(SC)的空腹血浆胰岛素水平进行了测量:结果:处于营养阶段 1a 和 1b 的 PWS 患者的血浆胰岛素水平与 SC 相当。然而,PWS 组从 1b 阶段过渡到 3 阶段时,胰岛素显著增加,同时体重增加、肥胖和多食。只有处于第3阶段的PWS患者的胰岛素水平与EMO组相当,而EMO组的胰岛素水平在任何年龄都高于SC组:结论:胰岛素信号升高可能是普拉德-威利综合征患儿体重增加和食欲亢进的诱因。在儿童早期体重增加之前调节胰岛素水平可能是调节普氏综合征患儿以及其他非普氏综合征早发肥胖症幼儿肥胖症和吞食过多症发病和严重程度的关键。通过药物治疗和/或饮食限制(如低碳水化合物、低血糖负荷的综合饮食)来预防或逆转 PWS 患者胰岛素水平的升高,可能是防治 PWS 儿童和其他早期肥胖儿童肥胖症的可行治疗策略。
{"title":"Hyperinsulinemia is a probable trigger for weight gain and hyperphagia in individuals with Prader-Willi syndrome.","authors":"Frederick A Kweh, Carlos R Sulsona, Jennifer L Miller, Daniel J Driscoll","doi":"10.1002/osp4.663","DOIUrl":"10.1002/osp4.663","url":null,"abstract":"<p><strong>Objective: </strong>Prader-Willi syndrome (PWS) is the most frequently diagnosed genetic cause of early childhood obesity. Individuals with PWS typically progress through 7 different nutritional phases during their lifetime. The main objective of this study was to assess potential factors, particularly insulin, that may be responsible for the weight gains in sub-phase 2a and their role in the subsequent increase in fat mass and obesity in sub-phase 2b and insatiable appetite in phase 3.</p><p><strong>Methods: </strong>Fasting plasma insulin levels were measured in children with PWS between the ages of 0-12 years and in age-matched non-PWS participants with early-onset major (clinically severe) obesity (EMO) and in healthy-weight sibling controls (SC).</p><p><strong>Results: </strong>Participants with PWS in nutritional phases 1a and 1b had plasma insulin levels comparable to SC. However, the transition from phase 1b up to phase 3 in the PWS group was accompanied by significant increases in insulin, coinciding in weight gains, obesity, and hyperphagia. Only individuals with PWS in phase 3 had comparable insulin levels to the EMO group who were higher than the SC group at any age.</p><p><strong>Conclusions: </strong>Elevated insulin signaling is a probable trigger for weight gain and onset of hyperphagia in children with Prader-Willi syndrome. Regulating insulin levels early in childhood before the onset of the early weight gain may be key in modulating the onset and severity of obesity and hyperphagia in individuals with PWS, as well as in other young children with non-PWS early-onset obesity. Preventing or reversing elevated insulin levels in PWS with pharmacological agents and/or through diet restrictions such as a combined low carbohydrate, low glycemic-load diet may be a viable therapeutic strategy in combating obesity in children with PWS and others with early childhood obesity.</p>","PeriodicalId":19448,"journal":{"name":"Obesity Science & Practice","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399533/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9955314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issue Information 问题信息
IF 2.2 Q3 Nursing Pub Date : 2023-02-01 DOI: 10.1002/osp4.609
No abstract is available for this article.
这篇文章没有摘要。
{"title":"Issue Information","authors":"","doi":"10.1002/osp4.609","DOIUrl":"https://doi.org/10.1002/osp4.609","url":null,"abstract":"No abstract is available for this article.","PeriodicalId":19448,"journal":{"name":"Obesity Science & Practice","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42640561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial for the special section: Obesity in Asia. 专题社论:亚洲的肥胖问题。
IF 2.2 Q3 Nursing Pub Date : 2023-02-01 DOI: 10.1002/osp4.662
David B Sarwer
{"title":"Editorial for the special section: Obesity in Asia.","authors":"David B Sarwer","doi":"10.1002/osp4.662","DOIUrl":"https://doi.org/10.1002/osp4.662","url":null,"abstract":"","PeriodicalId":19448,"journal":{"name":"Obesity Science & Practice","volume":null,"pages":null},"PeriodicalIF":2.2,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913184/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9268059","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Health state utilities associated with hyperphagia: Data for use in cost-utility models. 与多食相关的健康状态效用:用于成本效用模型的数据。
IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-02-01 eCollection Date: 2023-08-01 DOI: 10.1002/osp4.652
Timothy A Howell, Louis S Matza, Usha G Mallya, Anthony P Goldstone, W Scott Butsch, Ethan Lazarus

Objective: Rare genetic diseases of obesity typically present with hyperphagia, a pathologic desire to consume food. Cost-utility models assessing the value of treatments for these rare diseases will require health state utilities representing hyperphagia. This study estimated utilities associated with various hyperphagia severity levels.

Methods: Four health state vignettes were developed using published literature and clinician input to represent various severity levels of hyperphagia. Utilities were estimated for these health states in a time trade-off elicitation study in a UK general population sample.

Results: In total, 215 participants completed interviews (39.5% male; mean age 39.1 years). Mean (SD) utilities were 0.98 (0.02) for no hyperphagia, 0.91 (0.10) for mild hyperphagia, 0.70 (0.30) for moderate hyperphagia, and 0.22 (0.59) for severe hyperphagia. Mean (SD) disutilities were -0.08 (0.10) for mild, -0.28 (0.30) for moderate, and -0.77 (0.58) for severe hyperphagia.

Conclusions: These data show increasing severity of hyperphagia is associated with decreased utility. Utilities associated with severe hyperphagia are similar to those of other health conditions severely impacting quality of life (QoL). These findings highlight that treatments addressing substantial QoL impacts of severe hyperphagia are needed. Utilities estimated here may be useful in cost-utility models of treatments for rare genetic diseases of obesity.

目的:罕见的遗传性肥胖症通常表现为食欲亢进,这是一种病态的进食欲望。评估这些罕见疾病治疗价值的成本效用模型需要代表多食症的健康状态效用。本研究估算了与各种多食症严重程度相关的效用:方法:利用已发表的文献和临床医生的意见,开发了四种健康状态案例,以代表不同严重程度的吞咽过度。结果:共有 215 名参与者完成了访谈:共有 215 名参与者完成了访谈(39.5% 为男性;平均年龄为 39.1 岁)。无多食的平均(标清)效用为 0.98 (0.02),轻度多食为 0.91 (0.10),中度多食为 0.70 (0.30),重度多食为 0.22 (0.59)。轻度、中度和重度吞咽过多症的平均(标清)损耗分别为-0.08(0.10)、-0.28(0.30)和-0.77(0.58):这些数据表明,多食症严重程度的增加与效用的降低有关。与严重多食症相关的效用与其他严重影响生活质量(QoL)的健康状况相似。这些研究结果突出表明,需要针对严重多食症对生活质量的重大影响采取治疗措施。此处估算的效用可能有助于建立治疗罕见遗传性肥胖症的成本效用模型。
{"title":"Health state utilities associated with hyperphagia: Data for use in cost-utility models.","authors":"Timothy A Howell, Louis S Matza, Usha G Mallya, Anthony P Goldstone, W Scott Butsch, Ethan Lazarus","doi":"10.1002/osp4.652","DOIUrl":"10.1002/osp4.652","url":null,"abstract":"<p><strong>Objective: </strong>Rare genetic diseases of obesity typically present with hyperphagia, a pathologic desire to consume food. Cost-utility models assessing the value of treatments for these rare diseases will require health state utilities representing hyperphagia. This study estimated utilities associated with various hyperphagia severity levels.</p><p><strong>Methods: </strong>Four health state vignettes were developed using published literature and clinician input to represent various severity levels of hyperphagia. Utilities were estimated for these health states in a time trade-off elicitation study in a UK general population sample.</p><p><strong>Results: </strong>In total, 215 participants completed interviews (39.5% male; mean age 39.1 years). Mean (SD) utilities were 0.98 (0.02) for no hyperphagia, 0.91 (0.10) for mild hyperphagia, 0.70 (0.30) for moderate hyperphagia, and 0.22 (0.59) for severe hyperphagia. Mean (SD) disutilities were -0.08 (0.10) for mild, -0.28 (0.30) for moderate, and -0.77 (0.58) for severe hyperphagia.</p><p><strong>Conclusions: </strong>These data show increasing severity of hyperphagia is associated with decreased utility. Utilities associated with severe hyperphagia are similar to those of other health conditions severely impacting quality of life (QoL). These findings highlight that treatments addressing substantial QoL impacts of severe hyperphagia are needed. Utilities estimated here may be useful in cost-utility models of treatments for rare genetic diseases of obesity.</p>","PeriodicalId":19448,"journal":{"name":"Obesity Science & Practice","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/50/22/OSP4-9-376.PMC10399521.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9952843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultra-processed foods: Processing versus formulation. 超加工食品:加工与配方。
IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-26 eCollection Date: 2023-08-01 DOI: 10.1002/osp4.657
Allen S Levine, Job Ubbink

The four-tiered NOVA food classification defines foods based on their degree of processing and ranges from native unprocessed foods to so-called "ultra-processed" foods. Recent publications have suggested that foods classified as ultra-processed are unhealthy and contribute to the obesity epidemic. It is important to distinguish between formulation and processing of a food. In most cases it is the formulation more than the processing that results in foods that are not recommended as part of a healthy diet. Such "ultra-formulated" foods are unhealthy because they are high in added sugar and other caloric sweeteners, refined flours saturated fats and salt to increase palatability. The understanding that processing and formulation are distinct will assist health professionals in identifying the types of foods that are unhealthy and contribute to overconsumption and obesity. It furthermore will help to destigmatize food technology and promote discussions amongst health professionals, food scientists, corporate scientists, government officials and the general public. Novel food processing techniques are urgently needed in times of population growth, climate change and war-induced food shortages.

诺瓦食品四级分类法根据食品的加工程度来定义食品,从原生未加工食品到所谓的 "超加工 "食品。最近的出版物表明,被归类为 "超加工 "食品的食品是不健康的,会导致肥胖症的流行。必须区分食品的配制和加工。在大多数情况下,配方比加工更容易导致食品不被推荐为健康饮食的一部分。这种 "超配方 "食品是不健康的,因为它们添加了大量的糖和其他热量甜味剂、精制面粉、饱和脂肪和盐,以增加可口性。认识到加工和配制是截然不同的,将有助于卫生专业人员识别哪些类型的食品不健康并导致过度消费和肥胖。此外,它还有助于消除食品技术的污名化,促进卫生专业人员、食品科学家、企业科学家、政府官员和公众之间的讨论。在人口增长、气候变化和战争导致粮食短缺的时代,迫切需要新的食品加工技术。
{"title":"Ultra-processed foods: Processing versus formulation.","authors":"Allen S Levine, Job Ubbink","doi":"10.1002/osp4.657","DOIUrl":"10.1002/osp4.657","url":null,"abstract":"<p><p>The four-tiered NOVA food classification defines foods based on their degree of processing and ranges from native unprocessed foods to so-called \"ultra-processed\" foods. Recent publications have suggested that foods classified as ultra-processed are unhealthy and contribute to the obesity epidemic. It is important to distinguish between formulation and processing of a food. In most cases it is the formulation more than the processing that results in foods that are not recommended as part of a healthy diet. Such \"ultra-formulated\" foods are unhealthy because they are high in added sugar and other caloric sweeteners, refined flours saturated fats and salt to increase palatability. The understanding that processing and formulation are distinct will assist health professionals in identifying the types of foods that are unhealthy and contribute to overconsumption and obesity. It furthermore will help to destigmatize food technology and promote discussions amongst health professionals, food scientists, corporate scientists, government officials and the general public. Novel food processing techniques are urgently needed in times of population growth, climate change and war-induced food shortages.</p>","PeriodicalId":19448,"journal":{"name":"Obesity Science & Practice","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/73/34/OSP4-9-435.PMC10399516.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9952841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does anthocyanins consumption affect weight and body composition? A systematic review and meta-analysis of randomized controlled trials. 食用花青素会影响体重和身体组成吗?随机对照试验的系统回顾和荟萃分析。
IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-23 eCollection Date: 2023-02-01 DOI: 10.1002/osp4.651
Faezeh Yarhosseini, Mina Darand, Zohreh Sadat Sangsefidi, Hassan Mozaffari-Khosravi, Mahdieh Hosseinzadeh

Background and aims: Anthocyanins (ACNs) are water-soluble plant pigments belong to flavonoids with beneficial effects on health and disease prevention. Some studies have examined the effect of ACNs on anthropometric and body composition indices, but the findings were inconsistent. This systematic review and meta-analysis aimed to investigate the effect of ACNs and sources rich in anthocyanins on body mass index (BMI), body weight (BW), waist circumference (WC), hip circumference (HC), waist-hip ratio (WHR), percentage of fat mass (PFM) and fat free mass (FFM).

Methods: PubMed, Web of Science, Scopus, and Google Scholar were searched with no limitation until May 2021 to find relevant randomized controlled clinical trials (RCT). The risk of bias was assessed utilizing Cochrane collaboration's tool. Weighted mean differences (WMD) and 95% confidence intervals (CIs) were obtained using a random effects model.

Results: A total of 31 RCTs (with 0.77-640 mg/day of ACNs supplementation for 28-90 days) with 1438 participants were included. No significant effect was found in BMI, WC, HC, WHR, PFM and FFM after ACNs consumption.

Conclusions: The results showed that ACNs did not significantly affect anthropometric and body composition parameters. Further high-quality RCTs are required to validate these findings.

背景和目的:花青素(ACNs)是一种水溶性植物色素,属于黄酮类化合物,对健康和疾病预防有益。一些研究探讨了花青素对人体测量和身体成分指数的影响,但结果并不一致。本系统综述和荟萃分析旨在研究 ACNs 和富含花青素的来源对体重指数(BMI)、体重(BW)、腰围(WC)、臀围(HC)、腰臀比(WHR)、脂肪量百分比(PFM)和无脂肪量(FFM)的影响:在 2021 年 5 月之前,对 PubMed、Web of Science、Scopus 和 Google Scholar 进行了无限制检索,以找到相关的随机对照临床试验(RCT)。利用 Cochrane 协作工具评估了偏倚风险。采用随机效应模型得出加权平均差(WMD)和 95% 置信区间(CI):共纳入了 31 项 RCT(ACNs 补充量为 0.77-640 毫克/天,持续 28-90 天),1438 人参与了研究。结果:共纳入了 31 项研究(每天补充 0.77-640 毫克 ACNs,持续 28-90 天),1438 名参与者,结果显示,摄入 ACNs 后,BMI、WC、HC、WHR、PFM 和 FFM 均无明显影响:结果表明,ACNs 对人体测量和身体成分参数没有明显影响。需要进一步开展高质量的研究实验来验证这些发现。
{"title":"Does anthocyanins consumption affect weight and body composition? A systematic review and meta-analysis of randomized controlled trials.","authors":"Faezeh Yarhosseini, Mina Darand, Zohreh Sadat Sangsefidi, Hassan Mozaffari-Khosravi, Mahdieh Hosseinzadeh","doi":"10.1002/osp4.651","DOIUrl":"10.1002/osp4.651","url":null,"abstract":"<p><strong>Background and aims: </strong>Anthocyanins (ACNs) are water-soluble plant pigments belong to flavonoids with beneficial effects on health and disease prevention. Some studies have examined the effect of ACNs on anthropometric and body composition indices, but the findings were inconsistent. This systematic review and meta-analysis aimed to investigate the effect of ACNs and sources rich in anthocyanins on body mass index (BMI), body weight (BW), waist circumference (WC), hip circumference (HC), waist-hip ratio (WHR), percentage of fat mass (PFM) and fat free mass (FFM).</p><p><strong>Methods: </strong>PubMed, Web of Science, Scopus, and Google Scholar were searched with no limitation until May 2021 to find relevant randomized controlled clinical trials (RCT). The risk of bias was assessed utilizing Cochrane collaboration's tool. Weighted mean differences (WMD) and 95% confidence intervals (CIs) were obtained using a random effects model.</p><p><strong>Results: </strong>A total of 31 RCTs (with 0.77-640 mg/day of ACNs supplementation for 28-90 days) with 1438 participants were included. No significant effect was found in BMI, WC, HC, WHR, PFM and FFM after ACNs consumption.</p><p><strong>Conclusions: </strong>The results showed that ACNs did not significantly affect anthropometric and body composition parameters. Further high-quality RCTs are required to validate these findings.</p>","PeriodicalId":19448,"journal":{"name":"Obesity Science & Practice","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913187/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10744060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The impact of age and obesity on outcomes among patients hospitalized with COVID-19 in Denmark: A nationwide cohort study. 年龄和肥胖对丹麦 COVID-19 住院患者预后的影响:一项全国性队列研究。
IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-17 eCollection Date: 2023-08-01 DOI: 10.1002/osp4.659
Anton Lund Andersen, Sigrid Bjerge Gribsholt, Lars Pedersen, Reimar Wernich Thomsen, Thomas Lars Benfield, Ole Søgaard, Stig Lønberg Nielsen, Lars Haukali Omland, Birgitte Lindegaard, Bjørn Richelsen, Jacob Bodilsen, Jens Meldgaard Bruun

Purpose: Obesity may alter the severity of infection with Coronavirus disease 2019 (COVID-19). Age may impact the association between body weight and severity of COVID-19 in patients with obesity. The aim of the study was to examine the association between obesity and severity of infection in a Danish cohort hospitalized with COVID-19 in the initial wave of the pandemic.

Patients and methods: Based on data from the nationwide, clinical database: COVID-DK, risks of intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), and mortality were compared among patients with and without obesity. Interaction with age was examined and we used Inverse Probability of Treatment Weighting regression for confounder adjustment.

Results: Among 524 patients, 142 (27%) were admitted to the ICU, 112 (21%) required IMV, and 109 (21%) died. Compared to COVID-19 patients without obesity, patients with obesity displayed a non-significant increased risk of ICU admission (Relative Risk [RR] 1.19, 95% Confidence Interval [CI] 0.88; 1.60), IMV (RR 1.23, CI 0.86; 1.75) and mortality (RR 1.21, CI 0.84; 1.75). COVID-19 patients with obesity, <60 years had highly increased risk of ICU admission (RR 1.92, CI 1.14; 3.24) and IMV (RR 1.95, CI 1.09; 3.49).

Conclusions: In hospitalized COVID-19 patients, obesity conferred an approximately 20% increased risk for ICU admission, IMV, and death, although these relationships did not reach statistical significance. COVID-19 patients with obesity and <60 years had an almost doubled risk of ICU admission and IMV.

目的:肥胖可能会改变感染冠状病毒病 2019(COVID-19)的严重程度。年龄可能会影响肥胖患者的体重与 COVID-19 感染严重程度之间的关系。本研究的目的是研究在大流行初期因感染COVID-19而住院的丹麦队列中肥胖与感染严重程度之间的关系:患者和方法:基于全国性临床数据库的数据:COVID-DK的数据,比较了肥胖和非肥胖患者入住重症监护室(ICU)、进行有创机械通气(IMV)和死亡的风险。我们研究了肥胖与年龄的交互作用,并使用治疗加权反概率回归法调整混杂因素:在 524 名患者中,142 人(27%)住进了重症监护室,112 人(21%)需要进行 IMV,109 人(21%)死亡。与没有肥胖症的 COVID-19 患者相比,肥胖症患者入住 ICU(相对风险 [RR] 1.19,95% 置信区间 [CI] 0.88;1.60)、接受 IMV(RR 1.23,CI 0.86;1.75)和死亡(RR 1.21,CI 0.84;1.75)的风险均无显著增加。有肥胖症的 COVID-19 患者,结论:在住院的 COVID-19 患者中,肥胖会使入住 ICU、IMV 和死亡的风险增加约 20%,尽管这些关系未达到统计学意义。COVID-19 肥胖症患者和
{"title":"The impact of age and obesity on outcomes among patients hospitalized with COVID-19 in Denmark: A nationwide cohort study.","authors":"Anton Lund Andersen, Sigrid Bjerge Gribsholt, Lars Pedersen, Reimar Wernich Thomsen, Thomas Lars Benfield, Ole Søgaard, Stig Lønberg Nielsen, Lars Haukali Omland, Birgitte Lindegaard, Bjørn Richelsen, Jacob Bodilsen, Jens Meldgaard Bruun","doi":"10.1002/osp4.659","DOIUrl":"10.1002/osp4.659","url":null,"abstract":"<p><strong>Purpose: </strong>Obesity may alter the severity of infection with Coronavirus disease 2019 (COVID-19). Age may impact the association between body weight and severity of COVID-19 in patients with obesity. The aim of the study was to examine the association between obesity and severity of infection in a Danish cohort hospitalized with COVID-19 in the initial wave of the pandemic.</p><p><strong>Patients and methods: </strong>Based on data from the nationwide, clinical database: COVID-DK, risks of intensive care unit (ICU) admission, invasive mechanical ventilation (IMV), and mortality were compared among patients with and without obesity. Interaction with age was examined and we used Inverse Probability of Treatment Weighting regression for confounder adjustment.</p><p><strong>Results: </strong>Among 524 patients, 142 (27%) were admitted to the ICU, 112 (21%) required IMV, and 109 (21%) died. Compared to COVID-19 patients without obesity, patients with obesity displayed a non-significant increased risk of ICU admission (Relative Risk [RR] 1.19, 95% Confidence Interval [CI] 0.88; 1.60), IMV (RR 1.23, CI 0.86; 1.75) and mortality (RR 1.21, CI 0.84; 1.75). COVID-19 patients with obesity, <60 years had highly increased risk of ICU admission (RR 1.92, CI 1.14; 3.24) and IMV (RR 1.95, CI 1.09; 3.49).</p><p><strong>Conclusions: </strong>In hospitalized COVID-19 patients, obesity conferred an approximately 20% increased risk for ICU admission, IMV, and death, although these relationships did not reach statistical significance. COVID-19 patients with obesity and <60 years had an almost doubled risk of ICU admission and IMV.</p>","PeriodicalId":19448,"journal":{"name":"Obesity Science & Practice","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/69/OSP4-9-355.PMC10399535.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9952844","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the relationship between subclinical depressive symptoms and physical activity in behavioral weight loss treatment. 了解行为减肥治疗中亚临床抑郁症状与体育锻炼之间的关系。
IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-17 eCollection Date: 2023-08-01 DOI: 10.1002/osp4.661
Hannah C McCausland, Charlotte J Hagerman, Marny M Ehmann, Meghan L Butryn

Introduction: Many adults with overweight or obesity experience subclinical symptoms of depression, but little is known about how such symptoms are associated with physical activity (PA) or the experience of PA during behavioral weight loss (BWL) treatment.

Methods: In the current study, adults recruited from the community (N = 320) received 18 months of group-based BWL treatment and wore accelerometers at months 0, 6, and 18 to objectively measure PA. Participants with a mood disorder that was not well controlled were not eligible for the study and were referred for individual treatment. Depressive symptoms, PA barriers, discomfort avoidance, and self-control were self-reported with validated measures.

Results: At baseline, the majority of participants indicated some depressive symptoms, mostly at subclinical levels. Results of multilevel models suggest that depressive symptoms were not significantly associated with concurrent measures of PA engagement (minutes/week) or sedentary behavior (minutes/week) at a given time point (i.e., baseline, 6 months, or 18 months). Results of cross-level interactions suggest that baseline depressive symptoms did not moderate the change in PA or sedentary behavior across time. Concurrent depressive symptoms and PA barriers were significantly and positively associated at a given time point (i.e., baseline, 6 months, or 18 months); however, baseline depressive symptoms did not moderate the improvement in perceived PA barriers across time. At baseline, higher discomfort avoidance and lower self-control each independently and partially mediated the relationship between depressive symptoms and PA barriers.

Conclusion: Results suggest that, among BWL samples in which most participants do not have clinically significant depressive symptoms, the likelihood of adopting and sustaining PA does not depend on the extent of depressive symptoms, but those with elevated symptoms may benefit from approaches that address their perception that engaging in PA is especially challenging.

导言:许多超重或肥胖的成年人都会出现亚临床抑郁症状,但这些症状与体育锻炼(PA)或行为减肥(BWL)治疗期间的PA体验之间的关系却鲜为人知:在本研究中,从社区招募的成年人(N = 320)接受了为期 18 个月的集体行为减肥治疗,并在第 0、6 和 18 个月佩戴加速计来客观测量运动量。情绪障碍未得到很好控制的参与者没有资格参加本研究,他们将被转介接受个人治疗。抑郁症状、运动障碍、避免不适感和自我控制能力均通过有效的测量方法进行自我报告:结果:在基线时,大多数参与者都有一些抑郁症状,而且大多处于亚临床水平。多层次模型的结果表明,抑郁症状与特定时间点(即基线、6 个月或 18 个月)的活动参与度(分钟/周)或久坐行为(分钟/周)并无明显关联。跨水平交互作用的结果表明,基线抑郁症状并不影响不同时间段内的体育锻炼或久坐行为的变化。在特定时间点(即基线、6 个月或 18 个月),并发抑郁症状与 PA 障碍显著正相关;然而,基线抑郁症状并不影响不同时间段内感知到的 PA 障碍的改善。在基线时,较高的不适回避和较低的自我控制能力分别独立地、部分地调解了抑郁症状与PA障碍之间的关系:结果表明,在大多数参与者没有明显临床抑郁症状的白领样本中,采用和坚持体育锻炼的可能性并不取决于抑郁症状的程度,但症状加重的人可能会从解决他们认为参与体育锻炼特别具有挑战性的方法中获益。
{"title":"Understanding the relationship between subclinical depressive symptoms and physical activity in behavioral weight loss treatment.","authors":"Hannah C McCausland, Charlotte J Hagerman, Marny M Ehmann, Meghan L Butryn","doi":"10.1002/osp4.661","DOIUrl":"10.1002/osp4.661","url":null,"abstract":"<p><strong>Introduction: </strong>Many adults with overweight or obesity experience subclinical symptoms of depression, but little is known about how such symptoms are associated with physical activity (PA) or the experience of PA during behavioral weight loss (BWL) treatment.</p><p><strong>Methods: </strong>In the current study, adults recruited from the community (N = 320) received 18 months of group-based BWL treatment and wore accelerometers at months 0, 6, and 18 to objectively measure PA. Participants with a mood disorder that was not well controlled were not eligible for the study and were referred for individual treatment. Depressive symptoms, PA barriers, discomfort avoidance, and self-control were self-reported with validated measures.</p><p><strong>Results: </strong>At baseline, the majority of participants indicated some depressive symptoms, mostly at subclinical levels. Results of multilevel models suggest that depressive symptoms were not significantly associated with concurrent measures of PA engagement (minutes/week) or sedentary behavior (minutes/week) at a given time point (i.e., baseline, 6 months, or 18 months). Results of cross-level interactions suggest that baseline depressive symptoms did not moderate the change in PA or sedentary behavior across time. Concurrent depressive symptoms and PA barriers were significantly and positively associated at a given time point (i.e., baseline, 6 months, or 18 months); however, baseline depressive symptoms did not moderate the improvement in perceived PA barriers across time. At baseline, higher discomfort avoidance and lower self-control each independently and partially mediated the relationship between depressive symptoms and PA barriers.</p><p><strong>Conclusion: </strong>Results suggest that, among BWL samples in which most participants do not have clinically significant depressive symptoms, the likelihood of adopting and sustaining PA does not depend on the extent of depressive symptoms, but those with elevated symptoms may benefit from approaches that address their perception that engaging in PA is especially challenging.</p>","PeriodicalId":19448,"journal":{"name":"Obesity Science & Practice","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/cc/8f/OSP4-9-364.PMC10399524.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9955307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Waist-to-height ratio for the prediction of gallstone disease among different obesity indicators. 不同肥胖指标中预测胆石症的腰围身高比。
IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-12 eCollection Date: 2023-02-01 DOI: 10.1002/osp4.650
Tien-Shin Chou, Chih-Lang Lin, Li-Wei Chen, Ching-Chih Hu, Jia-Jang Chang, Cho-Li Yen, Shuo-Wei Chen, Ching-Jung Liu, Cheng-Hung Chien

Background: Factors of metabolic syndrome such as obesity are well-known risk factors for gallstone disease (GSD). There are different indicators of obesity, including weight, body mass index, waist circumference, and waist-to-height ratio. The predictive ability of different obesity indicators for GSD remains unclear.

Objective: To explore the most efficient predictor of GSD among the different anthropometric indicators of obesity.

Methods: This population-based cross-sectional study included 2263 participants who completed a questionnaire detailing their demographics, medical history, and lifestyle between 2014 and 2017 in Taiwan. Blood samples were collected and physical examinations, including anthropometric measurements, were performed. Gallstone disease was ascertained using ultrasonography. Multivariate analyses were performed to identify independent risk factors for GSD.

Results: The overall prevalence of GSD was 8.8%. According to the multivariate analysis, individuals with a waist-to-height ratio ≥0.5 (odds ratio|odds ratios (OR) = 1.65, 95% confidence interval (CI) = 1.10-2.48, p = 0.017) had an increased risk of GSD. Diabetes was the main risk factor for GSD in men (OR = 2.06, 95% CI = 1.17-3.65, p = 0.013). Among women, waist-to-height ratio >0.5 (OR = 1.76, 95% CI = 1.03-3.02, p = 0.040) and current hormone drug use (OR = 2.73, 95% CI = 1.09-6.84, p = 0.033) were significant risk factors for gallstones.

Conclusion: GSD was independently associated with central obesity and exogenous hormone intake in women. Among the anthropometric indicators used to assess central obesity, waist-to-height ratio was the most accurate predictor of GSD.

背景:肥胖等代谢综合征因素是众所周知的胆石症(GSD)风险因素。肥胖有不同的指标,包括体重、体重指数、腰围和腰围身高比。不同肥胖指标对 GSD 的预测能力仍不明确:在不同的肥胖人体测量指标中,探索最有效的 GSD 预测指标:这项基于人群的横断面研究纳入了 2263 名参与者,他们在 2014 年至 2017 年期间在台湾填写了一份调查问卷,详细描述了他们的人口统计学、病史和生活方式。研究人员采集了血液样本,并进行了包括人体测量在内的体格检查。胆石症通过超声波检查确定。研究人员进行了多变量分析,以确定GSD的独立风险因素:结果:GSD的总发病率为8.8%。根据多变量分析,腰围与身高比≥0.5(几率比|odds ratios (OR) = 1.65,95%置信区间 (CI) = 1.10-2.48,p = 0.017)的人患 GSD 的风险更高。糖尿病是男性 GSD 的主要风险因素(OR = 2.06,95% 置信区间 = 1.17-3.65,p = 0.013)。在女性中,腰围身高比大于 0.5(OR = 1.76,95% CI = 1.03-3.02,p = 0.040)和目前使用激素药物(OR = 2.73,95% CI = 1.09-6.84,p = 0.033)是胆结石的重要风险因素:结论:GSD 与女性的中心性肥胖和外源性激素摄入量密切相关。在用于评估中心性肥胖的人体测量指标中,腰围身高比是预测 GSD 的最准确指标。
{"title":"Waist-to-height ratio for the prediction of gallstone disease among different obesity indicators.","authors":"Tien-Shin Chou, Chih-Lang Lin, Li-Wei Chen, Ching-Chih Hu, Jia-Jang Chang, Cho-Li Yen, Shuo-Wei Chen, Ching-Jung Liu, Cheng-Hung Chien","doi":"10.1002/osp4.650","DOIUrl":"10.1002/osp4.650","url":null,"abstract":"<p><strong>Background: </strong>Factors of metabolic syndrome such as obesity are well-known risk factors for gallstone disease (GSD). There are different indicators of obesity, including weight, body mass index, waist circumference, and waist-to-height ratio. The predictive ability of different obesity indicators for GSD remains unclear.</p><p><strong>Objective: </strong>To explore the most efficient predictor of GSD among the different anthropometric indicators of obesity.</p><p><strong>Methods: </strong>This population-based cross-sectional study included 2263 participants who completed a questionnaire detailing their demographics, medical history, and lifestyle between 2014 and 2017 in Taiwan. Blood samples were collected and physical examinations, including anthropometric measurements, were performed. Gallstone disease was ascertained using ultrasonography. Multivariate analyses were performed to identify independent risk factors for GSD.</p><p><strong>Results: </strong>The overall prevalence of GSD was 8.8%. According to the multivariate analysis, individuals with a waist-to-height ratio ≥0.5 (odds ratio|odds ratios (OR) = 1.65, 95% confidence interval (CI) = 1.10-2.48, <i>p</i> = 0.017) had an increased risk of GSD. Diabetes was the main risk factor for GSD in men (OR = 2.06, 95% CI = 1.17-3.65, <i>p</i> = 0.013). Among women, waist-to-height ratio >0.5 (OR = 1.76, 95% CI = 1.03-3.02, <i>p</i> = 0.040) and current hormone drug use (OR = 2.73, 95% CI = 1.09-6.84, <i>p</i> = 0.033) were significant risk factors for gallstones.</p><p><strong>Conclusion: </strong>GSD was independently associated with central obesity and exogenous hormone intake in women. Among the anthropometric indicators used to assess central obesity, waist-to-height ratio was the most accurate predictor of GSD.</p>","PeriodicalId":19448,"journal":{"name":"Obesity Science & Practice","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913192/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10737782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Developing a long-term follow up service for bariatric surgical patients in the community: Patient and professional perspectives. 在社区为减肥手术患者提供长期随访服务:患者和专业人士的观点。
IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM Pub Date : 2023-01-12 eCollection Date: 2023-08-01 DOI: 10.1002/osp4.658
Yitka Graham, Ann Fox, Kamal Mahawar, Julie Parrott, Fadi Khalil, Catherine Hayes

Background: In the UK, bariatric surgical patients are followed up for 2 years post-operatively in hospital settings, before being discharged into General Practice for long-term follow-up. Presently, there is ambiguous guidance as to what should be included in a community-based bariatric surgical follow-up service. The aim of the study was to understand, from both patient and professional perspectives, what is needed to support the long-term management of bariatric surgical patients in community-based settings.

Methods: Post-surgical bariatric patients and General Practice staff were recruited from an area in the UK which has an National Health Service (NHS) hospital providing a high-volume and established bariatric surgical service. Data was collected through semi-structured interviews. A thematic analytic framework was used to construct eight themes which illuminated the participants' experiences. The study took place between March and December 2021.

Findings: Thirty participants (14 patients and 16 healthcare professionals) were recruited to the study. The study revealed the lack of a framework for delivery of a long-term follow up service was frustrating to both patients and professionals. Patient participants reported needing more support, especially dietetic and psychological input, and professionals stated they had little knowledge about bariatric surgical care, and what was needed to provide optimal care, but wanted to provide quality patient care.

Conclusion: Long-term follow up of bariatric surgical patients is an important issue which needs addressing. This study illuminates both the patient and professional perspectives on developing a pragmatic, community-based service which meets the needs of patients and considers the need to incorporate such a service into existing infrastructures without adding additional demands on General Practice.

背景:在英国,减肥手术患者术后要在医院接受两年的随访,然后才能出院到全科诊所接受长期随访。目前,关于社区减肥手术随访服务应包括哪些内容的指导并不明确。本研究旨在从患者和专业人员的角度,了解在社区环境中支持对减肥手术患者进行长期管理所需的条件:方法:在英国的一个地区招募了手术后的减肥患者和全科医生,该地区有一家国民健康服务(NHS)医院,提供大量成熟的减肥手术服务。通过半结构化访谈收集数据。采用主题分析框架构建了八个主题,这些主题揭示了参与者的经历。研究时间为 2021 年 3 月至 12 月:研究招募了 30 名参与者(14 名患者和 16 名医护人员)。研究显示,缺乏提供长期随访服务的框架令患者和专业人员都感到沮丧。参与研究的患者表示需要更多的支持,尤其是饮食和心理方面的支持,而专业人员则表示他们对减肥手术护理以及提供最佳护理所需的知识知之甚少,但他们希望为患者提供优质护理:减肥手术患者的长期随访是一个需要解决的重要问题。本研究从患者和专业人士的角度出发,探讨了如何发展一种务实的、以社区为基础的服务,以满足患者的需求,并考虑了将这种服务纳入现有基础设施的必要性,同时又不增加对全科医生的额外要求。
{"title":"Developing a long-term follow up service for bariatric surgical patients in the community: Patient and professional perspectives.","authors":"Yitka Graham, Ann Fox, Kamal Mahawar, Julie Parrott, Fadi Khalil, Catherine Hayes","doi":"10.1002/osp4.658","DOIUrl":"10.1002/osp4.658","url":null,"abstract":"<p><strong>Background: </strong>In the UK, bariatric surgical patients are followed up for 2 years post-operatively in hospital settings, before being discharged into General Practice for long-term follow-up. Presently, there is ambiguous guidance as to what should be included in a community-based bariatric surgical follow-up service. The aim of the study was to understand, from both patient and professional perspectives, what is needed to support the long-term management of bariatric surgical patients in community-based settings.</p><p><strong>Methods: </strong>Post-surgical bariatric patients and General Practice staff were recruited from an area in the UK which has an National Health Service (NHS) hospital providing a high-volume and established bariatric surgical service. Data was collected through semi-structured interviews. A thematic analytic framework was used to construct eight themes which illuminated the participants' experiences. The study took place between March and December 2021.</p><p><strong>Findings: </strong>Thirty participants (14 patients and 16 healthcare professionals) were recruited to the study. The study revealed the lack of a framework for delivery of a long-term follow up service was frustrating to both patients and professionals. Patient participants reported needing more support, especially dietetic and psychological input, and professionals stated they had little knowledge about bariatric surgical care, and what was needed to provide optimal care, but wanted to provide quality patient care.</p><p><strong>Conclusion: </strong>Long-term follow up of bariatric surgical patients is an important issue which needs addressing. This study illuminates both the patient and professional perspectives on developing a pragmatic, community-based service which meets the needs of patients and considers the need to incorporate such a service into existing infrastructures without adding additional demands on General Practice.</p>","PeriodicalId":19448,"journal":{"name":"Obesity Science & Practice","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399522/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9952839","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Obesity Science & Practice
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1